Efficacy and Safety of Oral Basal Insulin: Eight-Week Feasibility Study in People with Type 2 Diabetes (T2DM)

被引：0
|
作者：
Plum-Moerschel, Leona
Heise, Tim
Zijlstra, Eric
Lyby, Karsten
Wassermann, Karsten
Brondsted, Lise
Halberg, Inge Birk
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
380-OR
引用
收藏
页码：A100 / A100
页数：1
相关论文
共 50 条
  • [31] Treat to target? Efficacy of insulin use in patients with Type 2 diabetes (T2DM) in a secondary care setting
    Muraleedharan, V.
    Caddick, L.
    Hardisty, C.
    Tesfaye, S.
    Scott, A.
    DIABETIC MEDICINE, 2007, 24 : 75 - 75
  • [32] Psychosocial adjustment and outcomes of glycaemic control with basal insulin therapy in patients with type 2 diabetes mellitus (T2DM)
    Tanenberg, R. J.
    Zhang, Q.
    Zisman, A.
    DIABETOLOGIA, 2007, 50 : S435 - S436
  • [33] EFFICACY AND SAFETY OF INSULIN GLARGINE 300 U/ML IN PEOPLE WITH TYPE 2 DIABETES MELLITUS UNCONTROLLED ON BASAL INSULINS: ARTEMIS-DM STUDY
    Sethi, B.
    Al-Rubeaan, K.
    Unubol, M.
    Mabunay, M. A. N.
    Naqvi, M.
    Berthou, B.
    Pilorget, V.
    Frechtel, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A101 - A101
  • [34] Physician beliefs in efficacy of insulin glargine (GLAR) are associated with glucose control in type 2 diabetes (T2DM)
    Herman, W.
    Zhang, Q.
    Kennedy, L.
    DIABETOLOGIA, 2006, 49 : 527 - 528
  • [35] Immunogenicity, Safety, and Efficacy of Influenza Vaccine in T2DM and T2DM with Chronic Kidney Disease
    Heryaman, Henhen
    Juli, Cep
    Nazir, Arnengsih
    Syamsunarno, Mas Rizky A. A.
    Yahaya, Badrul Hisham
    Turbawaty, Dewi Kartika
    Sari, Rini Mulia
    Permana, Hikmat
    Supriyadi, Rudi
    Atik, Nur
    VACCINES, 2024, 12 (03)
  • [36] New Insulin U300: Blood Sugar Control and Hypoglycemic for People with Type-2-Diabetes (T2DM) under Handling with Basal Insulin and Oral Antidiabetics (OADs) (EDITION II)
    Mihaljevic, Roman
    Haslacher, Christoph
    Yki-Jarvinen, Hannele
    Riddle, Matthew
    Ziemen, Monika
    Wardecki, Marek
    Muehlen-Bartmer, Isabel
    Boelle, Emmanuelle
    Bergenstal, Richard
    WIENER KLINISCHE WOCHENSCHRIFT, 2014, 126 : S179 - S179
  • [37] Factors Associated with Insulin Intensification Strategies in Uncontrolled Type 2 Diabetes (T2DM)
    Korytkowski, Mary T.
    Lombardero, Manuel
    Brooks, Maria M.
    Orchard, Trevor J.
    Kanter, Justin
    Siminerio, Linda M.
    DIABETES, 2014, 63 : A307 - A307
  • [38] A retrospective study of adolescents with presumed type 2 diabetes mellitus (T2DM) treated with oral agents
    Kadmon, P
    Gruppuso, PA
    PEDIATRIC RESEARCH, 2000, 47 (04) : 132A - 132A
  • [39] Physiologic Dose Response Effects of Insulin Glargine in Type 2 Diabetes (T2DM
    Wang, Zhihui
    Briscoe, Vanessa J.
    Hedrington, Maka S.
    Gogitidze, Nino
    Richardson, Antoinette
    Ertl, Andrew C.
    Davis, Stephen N.
    DIABETES, 2009, 58 : A150 - A150
  • [40] The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM)
    Stedman, Mike
    Rea, Rustam
    Duff, Christopher J.
    Livingston, Mark
    McLoughlin, Katie
    Wong, Louise
    Brown, Stephen
    Grady, Katherine
    Gadsby, Roger
    Gibson, John M.
    Paisley, Angela
    Fryer, Anthony A.
    Heald, Adrian H.
    ENDOCRINOLOGY DIABETES & METABOLISM, 2022, 5 (02)
12345